Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial (NCT03011684)
🩺 Plain-English Summary (8th-Grade Level)
Latrogenic infertility as a result of cancer treatment has a profound effect on long-term quality of life in survivors of reproductive-age cancers. Oocyte cryopreservation prior to cancer treatment has been associated with improved quality of life, with a potential ability to reduce long-term decision-related regret in cancer survivors. Though letrozole plus gonadotropin and and tamoxifen plus gonadotropin are currently routinely used worldwide in ovarian stimulation cycles for fertility preservation in patients with estrogen-receptor-positive breast cancer, it is not clear which of the two might lead to improved oocyte yield. Improved knowledge about the efficacy of these medications, with regard to oocyte yield, has the potential to significantly improve quality of life in reproductive-age breast cancer survivors.
Who can join: Review the eligibility criteria below.
Location: University of California at San Francisco — San Francisco, California
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of California at San Francisco — San Francisco, California
📞 Contact the Study Coordinator
Phone: (415) 353-4305
Email: Rebecca.Wong@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Infertility
- ANXA5 M2 Haplotyping in IVF Patients and Embryos — North Brunswick, New Jersey
- Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp — Aurora, Colorado
- Fast Track to Fertility — Philadelphia, Pennsylvania
- Group Preconception Care for Fertility Patients — Philadelphia, Pennsylvania
- To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles. — Farmington, Connecticut
- Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield — Basking Ridge, New Jersey
Explore by condition: All Infertility clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.